328 related articles for article (PubMed ID: 16478285)
1. Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?
Ho L; Qin W; Stetka BS; Pasinetti GM
CNS Drugs; 2006; 20(2):85-98. PubMed ID: 16478285
[TBL] [Abstract][Full Text] [Related]
2. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
3. Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.
McGeer PL
Drugs Aging; 2000 Jul; 17(1):1-11. PubMed ID: 10933512
[TBL] [Abstract][Full Text] [Related]
4. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
Pasinetti GM
J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase as a target for the antiamyloidogenic activities of nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
Pasinetti GM
Neurosignals; 2002; 11(5):293-7. PubMed ID: 12566930
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-1 and -2 in the different stages of Alzheimer's disease pathology.
Hoozemans JJ; Rozemuller JM; van Haastert ES; Veerhuis R; Eikelenboom P
Curr Pharm Des; 2008; 14(14):1419-27. PubMed ID: 18537664
[TBL] [Abstract][Full Text] [Related]
8. [The role of cyclooxygenases in neurotoxicity of amyloid beta peptides in Alzheimer's disease].
Cakała M; Strosznajder JB
Neurol Neurochir Pol; 2010; 44(1):65-79. PubMed ID: 20358486
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence.
Szekely CA; Zandi PP
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):132-9. PubMed ID: 20205647
[TBL] [Abstract][Full Text] [Related]
10. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
Townsend KP; Praticò D
FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
[TBL] [Abstract][Full Text] [Related]
11. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
Doraiswamy PM
CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase inhibitors: a novel direction for Alzheimer's management.
Nivsarkar M; Banerjee A; Padh H
Pharmacol Rep; 2008; 60(5):692-8. PubMed ID: 19066416
[TBL] [Abstract][Full Text] [Related]
13. Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors.
Giovannini MG; Scali C; Prosperi C; Bellucci A; Pepeu G; Casamenti F
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):31-40. PubMed ID: 14552702
[TBL] [Abstract][Full Text] [Related]
14. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2009 Aug; 18(8):1147-68. PubMed ID: 19589092
[TBL] [Abstract][Full Text] [Related]
15. The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs.
Hoozemans JJ; O'Banion MK
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):307-15. PubMed ID: 15975032
[TBL] [Abstract][Full Text] [Related]
16. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
17. NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?
Weggen S; Rogers M; Eriksen J
Trends Pharmacol Sci; 2007 Oct; 28(10):536-43. PubMed ID: 17900710
[TBL] [Abstract][Full Text] [Related]
18. Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?
Savage R
Drugs Aging; 2005; 22(3):185-200. PubMed ID: 15813652
[TBL] [Abstract][Full Text] [Related]
19. [Prescription of NSAIDs in patients treatment with platelet inhibitors or anticoagulants].
Avouac B; Combe B; Darné B
Presse Med; 2003 Nov; 32(37 Pt 2):S38-43. PubMed ID: 14763353
[TBL] [Abstract][Full Text] [Related]
20. [The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].
de Jong D; Jansen RW; Verbeek MM; Kremer HP
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2074-8. PubMed ID: 12448960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
